Brokers Suggest Investing in Medtronic (MDT): Read This Before Placing a Bet

While Wall Street brokers maintain a Buy-equivalent average recommendation (ABR of 1.90) for Medtronic with 51.7% Strong Buy ratings, the article cautions that brokerage recommendations often suffer from positive bias due to vested interests. Medtronic's Zacks Rank of #3 (Hold) reflects unchanged earnings estimates, suggesting the stock may perform in line with the broader market rather than outperform.